Raleigh-based Icagen lands potential $274M+ development deal with Roche
Date Published:
RALEIGH – Icagen, the Raleigh-based firm focused on small molecule research with the potential for use in new drugs, has…
biopharmaceuticals
RTP-based AskBio taps former Chimerix exec as chief financial officer
Date Published:
RESEARCH TRIANGLE PARK – Asklepios BioPharmaceutical (AskBio) is tapping a former Chimerix exec to be part of its C-Suite.
The…
Raleigh’s RedHill Biopharma approved for US COVID-19 study
Date Published:
RALEIGH — Fresh off a small – but successful – COVID-19 study in Israel, RedHill Biopharma has received approval to…
Flush with $22M, newly merged 9 Meters Biopharma launches in Raleigh with focus on GI diseases
Date Published:
RALEIGH — Introducing 9 Meters Biopharma, the new company birthed from the merger of Raleigh-based Innovate Biopharmaceuticals, a clinical stage…
Durham’s Chimerix gets FDA nod to test cancer drug in COVID-19 patients
Date Published:
DURHAM — Chimerix has gotten the green light to test an investigational cancer drug to treat COVID-19 patients.
The Durham-based…
Raleigh pharma to have second drug tested for potential COVID-19 treatment
Date Published:
With fresh data from existing trials treating COVID-19 patients in Italy and Israel, a Triangle drugmaker has announced a deal…
RedHill Biopharma, which has US HQ in Raleigh, pursues second COVID-19 treatment
Date Published:
RALEIGH – RedHill Biopharma is another step closer to getting one of its potential treatments for COVID-19 tested.
The Israeli…
Raleigh pharma’s potential COVID-19 treatment to be used in Italy
Date Published:
A Triangle pharmaceutical organization has received special approval from the Italian government for use of its drug in the fight…